Metabolic-Fit / 100
He and She MD review
Semaglutide runs $199/mo month-to-month and tirzepatide $299, falling to $99 and $159 only if you prepay a full year — and the platform names its pharmacies, its clinical group and its chief medical officer, which most of this roster does not. The catch is the middle of the ladder: the 6-month rates are introductory and renew higher, and there is no postpartum or PCOS content anywhere on the site.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Referral link, walled off from the score
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
He and She MD at a glance
- Semaglutide
- $199/mo month-to-month, $99/mo on the 12-month plan
- Tirzepatide
- $299/mo month-to-month, $159/mo on the 12-month plan
- Coverage
- 49 states — everywhere except Louisiana
- Brand-name
- Yes
How we scored He and She MD
Every factor comes from He and She MD's own published pricing, disclosures and oversight, and the six combine into the 47/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- www.heandshemd.com/weight-loss/plans
$199 for semaglutide and $299 for tirzepatide month to month, both published openly on the plans page. The cheaper $99 and $159 headlines are twelve months paid up front — $1,188 and $1,908 in a single charge — and the arithmetic across all four prepay terms reconciles. Every state except Louisiana.
What to expect when you sign up
We walked He and She MD's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The plans page lists four terms per molecule — monthly, 3-month, 6-month and 12-month — each with both its monthly equivalent and the total charge, all before any intake
- 2A 5-minute assessment determines eligibility; a licensed U.S. provider reviews it in about 24 hours, and the site states you are only charged if prescribed
- 3If prescribed, medication ships in 2-3 days from a partner pharmacy with tracking; every plan states it includes injection supplies, shipping and unlimited provider messaging
What we noticed
- The month-to-month rate is now published for both molecules — $199 semaglutide, $299 tirzepatide. Earlier in 2026 neither figure appeared anywhere public
- The 6-month tier is an introductory rate, not a standing one: the plans page shows '$139/mo, SAVE $360' with no renewal figure, and the homepage footnote supplies the missing half — $1,194 per six months, or $199/mo, thereafter
- The FAQ names both pharmacy partners, the clinical group and its address, and states GLP-1s ship everywhere except Louisiana — a sentence that contradicts the 'nationwide' framing used elsewhere on the site
- The Terms of Service is Bask Health Inc's platform document, still carrying a testosterone-program membership section and three unfilled '[INSERT CUSTOMER SERVICE PHONE]' placeholders
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $199 | Injectable, month-to-monthThe standing no-commitment rate, shown on the plans page as 'MONTHLY PLAN … Billed monthly'. Every cheaper figure on that page buys a fixed term up front. |
| Compounded semaglutide | $149 | Injectable, 3-month planPay $447 every 3 months. Its 'SAVE $270' badge does not reconcile with anything the site publishes — against the $199 monthly plan the real 3-month saving is $150. |
| Compounded semaglutide | $139 → $199 | Injectable, 6-month plan$139/mo ($834) covers the FIRST six months only; the homepage footnote states it then renews at $1,194 per six months, i.e. $199/mo. The plans page shows the $139 and a 'SAVE $360' badge but never the renewal that badge is measured against. |
| Compounded semaglutide | $99 | Injectable, 12-month planPay $1,188 annually — the lowest advertised price on the site, and the longest commitment on it. |
| Oral semaglutide | $209 | Oral, 12-month planPrice for a 12-month supply purchase. A separate 6-month oral offer runs $199/mo for the first six months, then renews at $1,434 per six months, i.e. $239/mo. |
| Brand semaglutide | $1299 | Ozempic®, 12-month planPrice for a 12-month supply purchase. |
| Compounded tirzepatide | $299 | Injectable, month-to-monthThe standing no-commitment rate. This is the figure the August 2, 2026 record recorded as unpublished; it is itemized on the plans page now, and it is $100 above semaglutide's. |
| Compounded tirzepatide | $209 | Injectable, 3-month planPay $627 every 3 months; its 'SAVE $270' badge does reconcile against the $299 monthly plan. |
| Compounded tirzepatide | $199 → $289 | Injectable, 6-month plan$199/mo ($1,194) covers the FIRST six months only; the homepage footnote states it then renews at $1,734 per six months, i.e. $289/mo — which the plans page does not show. |
| Compounded tirzepatide | $159 | Injectable, 12-month planPay $1,908 annually, in one charge. |
| Oral tirzepatide | $269 | Oral, 12-month planPrice for a 12-month supply purchase. |
| Brand tirzepatide | $1399 | Zepbound®, 12-month planPrice for a 12-month supply purchase. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what He and She MD's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- A genuinely broad menu — compounded injectable, compounded oral, and FDA-approved brand (Ozempic, Zepbound) for both molecules, all priced on one platform
- Both month-to-month rates are published now ($199 semaglutide, $299 tirzepatide), so you can see what not committing actually costs — most of this roster shows only the prepay figure
- Names its pharmacies, its clinical group (Wasef Health PC) and its chief medical officer (Dr. Ozita Cooper, MD, dual board-certified in obesity medicine) — most of this roster names none of the three
- Every plan states it includes the medication, injection supplies, shipping and unlimited provider messaging, and that you are only charged if prescribed
- Same price at every dose, so titrating up never raises the bill
The caveats
- The 6-month tiers are introductory: semaglutide's $139/mo renews at $199/mo and tirzepatide's $199/mo at $289/mo, and the plans page shows the discount without the renewal
- The lowest advertised prices need 12 months paid up front — $1,188 for semaglutide, $1,908 for tirzepatide, in a single charge
- GLP-1s do not ship to Louisiana, which the FAQ states plainly and the rest of the site's 'nationwide' framing does not
- The Terms of Service bills 'approximately every 28-30 days' rather than monthly and makes membership fees non-refundable on cancellation, against a plans page badge reading 'No membership fees'
- No mention anywhere of pregnancy, breastfeeding, postpartum care, or PCOS — a crawl of all 94 indexed pages returned zero hits for any of them
He and She MD for mothers: our verdict
Semaglutide runs $199/mo month-to-month and tirzepatide $299, falling to $99 and $159 only if you prepay a full year — and the platform names its pharmacies, its clinical group and its chief medical officer, which most of this roster does not. The catch is the middle of the ladder: the 6-month rates are introductory and renew higher, and there is no postpartum or PCOS content anywhere on the site. The advertised entry is $139, but the standing rate settles near $199/month — so read the headline as a starting offer, not the monthly cost.
We weigh He and She MD the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What He and She MD costs, in full
- Compounded semaglutide — Injectable, month-to-month: $199/mo
- Compounded semaglutide — Injectable, 3-month plan: $149/mo
- Compounded semaglutide — Injectable, 6-month plan: $139 to start, then $199/mo
- Compounded semaglutide — Injectable, 12-month plan: $99/mo
- Oral semaglutide — Oral, 12-month plan: $209/mo
- Brand-name semaglutide — Ozempic®, 12-month plan: $1299/mo
That lands within a few dollars of the ~$179/month median across the providers we track, so the monthly cost isn't what should decide this one either way. Weigh it instead on postpartum and breastfeeding timing and PCOS and insulin resistance, and on what the price actually includes — a lower number that leaves out labs, visits or shipping is not the cheaper option.
He and She MD says the price covers the provider visit, the medication and shipping, and that lab work is billed separately. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications He and She MD prescribes
He and She MD prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. Brand pens are available here alongside the compounded versions, and the on-label products come with the manufacturer's own pregnancy and lactation labeling — easier to hand to an OB.
A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where He and She MD fits — and where it doesn't — for mothers
A good fit if…
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
Look elsewhere if…
- you want frictionless cancellation — read the cancellation and refund terms in the caveats above before you pay.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Everything He and She MD states publicly checked out at last review: pricing, pharmacies and clinical network were all verifiable. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
He and She MD is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers who want brand-name and oral options alongside compounded on one platform, and who will either pay $199/mo month-to-month or prepay a year to reach $99.
Alternatives to He and She MD
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing He and She MD
Head-to-head & alternatives
He and She MD, answered
- How much does He and She MD cost?
- At last review, He and She MD's lowest ongoing compounded rate was about $199 a month — $199/mo month-to-month, $99/mo on the 12-month plan for semaglutide, $299/mo month-to-month, $159/mo on the 12-month plan for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is He and She MD safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. He and She MD is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does He and She MD offer both semaglutide and tirzepatide?
- Yes — He and She MD offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does He and She MD rank for mothers?
- He and She MD scores 47/100 on our Metabolic-Fit Score and sits at #132. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect He and She MD's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.